GENEX

GENEX is a health care startup founded in 2019 with a strong focus on harnessing genomic insights for breakthroughs in drug discovery, development, and disease diagnosis through secure, comprehensive molecular testing solutions. The company provides comprehensive genome molecular testing services to the pharmaceutical sector and its supporting organizations. Their offerings encompass drug discovery and development pipelines along with essential services such as documentation, ethics procedures, patient outreach, electronic informed consent, sample collection, genomic analysis, and data storage and management. With secure cloud-based storage for genomic information, they facilitate diagnoses and clinical trials for mitochondrial disease. GENEX's Seed Round investment at 29 January 2021 was backed by notable investors including Monex Ventures, Kaken Pharmaceutical, and Sugi Medicine. This innovative startup presents an exciting opportunity for potential investors looking to tap into the rapidly evolving genomics and molecular testing market.